Company Overview and News
Semiconductor earnings seen growing 38%, but effects of China tariffs in forecasts are where the big uncertainty lies
MRVL XLNX LRCX SLAB HXSCF BC94 CRUS SMSN AMD NVDA MPWR SWKS TER MU AMAT AVGO ADI MKSI BRCM INTC QCOM SMSD HXSCL
Cadence Design Systems Inc. (CDNS - Free Report) is set to report second-quarter 2018 results on Jul 23. Notably, the company has surpassed the Zacks Consensus Estimate in three of the trailing four quarters while coming in line in the remaining one, recording an average positive surprise of 2.81%.
SWKS ASX MSFT AMD CDNS
Investors are always looking for stocks that are poised to beat at earnings season Skyworks Solutions, Inc. (SWKS - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
OCUL SWKS JAKK FTRPR FTR
SAP SE (SAP - Free Report) is expected to report second-quarter 2018 results before the opening bell on Jul 19. Notably, the company has a positive record of earnings surprises in the trailing four quarters, with an average beat of 6.1%. In the last reported quarter, the company delivered a positive earnings surprise of 3.5%.
IBM SWKS SAP SAPGF VEEV RL AMD RB SGH CALD
Chicago, IL – July 16, 2018 – Zacks Equity Research highlights Funko (FNKO - Free Report) as the Bull of the Day and GTT Communications (GTT - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Netflix, Inc. (NFLX - Free Report) , Microsoft Corp. (MSFT - Free Report) and Skyworks Solutions, Inc. (SWKS - Free Report) .
RM AMC NFLX ETM.WI FITBI ETM SWKS MTCH ROSEU GTT FNKO MSFT FITB PAA NMM ROSE
Skyworks Solutions Inc. (SWKS - Free Report) is set to release third-quarter fiscal 2018 results on Jul 19. The company beat the Zacks Consensus Estimate in the trailing four quarters, with an average positive surprise of 3.8%.
SWKS POOL GTT MLNX AAPL TXT
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
KMI.WS ECOR PLNT KMI.PRA PKG AEP NINE ADT GE COF-P GILD TMUS PDYPF SYF XERS JNJ VZ MSFT ADS KZR NNN EIDX FB RF.PRB AVRO RF.PRA HOPE NFLX AXP EHC BAC COF-D SEAS COF-C COF-F KR KS IIIV PNFP AAPL DDOC AEP.PRA SJM INPAP SIX JPM GNE WRK LGEJY KMRFZ DE 39IB KMX COF.WS RF UAL WMT CFIN LGEAF IP AMZN MGTA NTRS HON KMI CIWV GM.WS.A GM.WS.B HCSG GM.WS.C KMR CVB VLKAY LGEIY EBAY EPRT STT SLB BAC DFS LGEPF STM BBY BX BK STM LTXB LGLD SLB GM.WSB FOXA CLW COF.PRG COF.PRH PM STT.PRC STT.PRE NTRSP STT.PRD STT.PRG AUTL COF.PRP DLPH SWKS GS SWK TRTX GM PII COF.PRC COF.PRD DIS NEE COF.PRF IBM MOR F GEC C CMCSA COF FUN FUL CFG HBAN NEE.PRI XEL NEE.PRJ TGT BLK S PPG T NEE.PRC NEE.PRQ NEE.PRR SNE DPZ
Earnings season unofficially kicked off this morning with the reports of big financials like JPMorgan (JPM - Free Report) , Citigroup (C - Free Report) , and Wells Fargo (WFC - Free Report) coming in before the bell. Those reports were a mixed bag, with industry headwinds weighing down each stock more than anything else, and investors will now look ahead to one of first busy weeks of another key reporting period.
WFC WFCNP WFC.WS C WFC.PRL NFLX WFC.PRJ WFC.PRT SWKS WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN MSFT WFC.PRY WFC.PRX WFC.PRW WFC.PRV
One stock that might be an intriguing choice for investors right now is Skyworks Solutions, Inc. (SWKS - Free Report) . This is because this security in the Semiconductors - Radio Frequency space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.
Shares of Xiaomi Corp. declined 5.9% at the beginning of its first day of trading on Jul 9, at the Hong Kong Stock Exchange. The Chinese smartphone manufacturer managed to raise just $54 billion, far below its expectations. In what was touted be one of the biggest IPOs of the year, this definitely is a disappointing start for the world’s fourth-largest mobile phone maker.
SWKS BABA FB MU 0700 AAPL AVGO NVDA BRCM INTC
The United States formally imposed the first set of tariffs on $34 billion worth of Chinese imports on Jul 6. The trade war has finally been triggered, with China firing counter tariffs on an equal amount on imports from the United States.
QRVO STLD CAT AA.PRB KALU NUE MRC SWKS X AAI GM.WS.A BOE AA.PR GM.WS.B AVGO GM.WS.C GM BRCM FCAU INTC BA GM.WSB AA
Qorvo shares will rise as the chipmaker benefits from improving phone demand in China, according to KeyBanc Capital Markets.
Even though U.S. equities have been wavering in the weeks heading into the third quarter, they have been strong over the past several years. In fact, since the bottom in March 2009, U.S. stocks have been on quite the run. That’s particularly true for technology stocks. It has left investors feeling left out and feeling as though even the cheapest tech stocks are still too expensive.
IBM SWKS FB GOOGL AAPL AMD GOOG NVDA INTC
While several financial articles today focus on retiring well, getting there is another story. Theoretically, one could put off retirement planning and hope for a big payday down the road. However, the smartest approach is to start early. Especially when you’re in your twenties, you have a wealth of so-called Millennial stocks to consider.
CY NDBKY GOOG NVDA CRM WMT NDBKF GBTC SWKS FEYE AMZN NDAQ CSV GOOGL GRMN AAPL TSLA VSH MSFT SNE SQM BIDU
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to SWKS / Skyworks Solutions, Inc. on message board site Silicon Investor.
|SWKS - Skyworks Solutions, Inc (was AHAA)||Skyworks (SWKS)|
|SWKS - Skyworks Solutions, Inc.|
as of ET